Kidney Transplantation Clinical Trial
Official title:
Illness Perception and Coping in Kidney Transplant Recipients: a Mixed Research Based on Common Sense Model
The goal of this observational study is to learn about the current status of illness perception and the distribution of coping styles in kidney transplant recipients. The main question clarifies the current status and experience of illness perception in post-transplant patients with different coping styles, and aims to provide a reference basis for intervention of illness perception in kidney transplant patients, with the aim of improving their current status of illness perception, optimizing their awareness of treatment management and self-care behaviors, and perfecting the modern medical service system. Participants will describe the main tasks participants will be asked to do.
Status | Not yet recruiting |
Enrollment | 220 |
Est. completion date | December 31, 2024 |
Est. primary completion date | August 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 55 Years |
Eligibility | Inclusion Criteria: Patients between the ages of 18 and 55 who have received a kidney transplant and have been discharged from the hospital for at least 3 months. Patients must have basic communication skills and be willing to participate in the survey voluntarily by signing the informed consent form. Exclusion Criteria: (i) Patients with a history of other malignant tumors; (ii) patients who are participating in other clinical trials or related treatments; (iii) patients with other serious physical diseases; and (iv) kidney transplant patients with psychiatric disorders, serious cognitive impairment, or speech defects that prevent them from cooperating. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Wu Jiangxue | Zunyi Medical College |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the current state of illness perception | Using The general information questionnaire to measure | 2024.01-2024.12 | |
Primary | the distribution of coping styles in kidney transplant recipients | Using Simplified Coping Style Questionnaire to measure | 2024.01-2024.12 | |
Primary | the causes of differences in illness perceptions of different coping styles | UsingThe Brief Illness Perception Questionnaire to measure | 2024.01-2024.12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04910867 -
APOL1 Genetic Testing Program for Living Donors
|
N/A | |
Completed |
NCT02723591 -
To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients
|
Phase 4 | |
Completed |
NCT05945511 -
Silent Gallbladder Stone in Kidney Transplantation Recipients: Should it be Treated?
|
||
Completed |
NCT02234349 -
Bile Acids and Incretins in Pancreas Kidney Transplant Patients
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 | |
Recruiting |
NCT05917795 -
Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
|
N/A | |
Not yet recruiting |
NCT05934383 -
Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled Hypertension
|
N/A | |
Withdrawn |
NCT04936971 -
Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response
|
Phase 4 | |
Not yet recruiting |
NCT04540640 -
Oxygenated Machine Preservation in Kidney Transplantation
|
N/A | |
Not yet recruiting |
NCT03090828 -
Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
|
N/A | |
Recruiting |
NCT02908139 -
Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients
|
N/A | |
Completed |
NCT02560558 -
Bela 8 Week Dosing
|
Phase 4 | |
Terminated |
NCT02417870 -
Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation
|
Phase 1/Phase 2 | |
Recruiting |
NCT02154815 -
Pre-emptive Kidney Transplantation Quality of Life
|
N/A | |
Completed |
NCT02235571 -
iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
|
N/A | |
Enrolling by invitation |
NCT01905514 -
ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients
|
N/A | |
Completed |
NCT02147210 -
Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1
|
N/A | |
Recruiting |
NCT01699360 -
The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients
|
Phase 4 | |
Terminated |
NCT01436305 -
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
|
Phase 2 | |
Completed |
NCT01672957 -
ORANGE Study: An Observational Study on Renal Function in Kidney Transplant Patients on Immunosuppressive Therapy Containing CellCept (Mycophenolate Mofetil)
|
N/A |